A manufacturing problem in millions of Abbott glucose sensors for diabetes patients has been tied to at least seven deaths ...
About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.
Patients alarmed after glucose monitors used by diabetics are recalled after links to 7 deaths - Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warni ...
Medical Device Network on MSN
Abbott reports positive FreeDM2 study results for CGM
The study was carried out at 24 clinical sites across the UK and included 303 participants.
KPNX-TV Phoenix on MSN
There's a recall on this glucose monitor. Here's what we know
About 3 million ‘Freestyle Libre 3 and 3 plus are being recalled because they can give dangerous false readings.
Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous glucose monitoring (CGM) ...
FreeDM2 randomized controlled trial shows Libre technology helps people with type 2 diabetes on basal insulin improve glucose management: Abbott Park, Illinois Saturday, March 14, ...
Rachel Newton is grateful she caught the small change in her cat's behavior when she did ...
On the heels of its debut as a public company, Medtronic’s former diabetes division MiniMed has claimed a European approval to connect its mainstay insulin pump with an exclusive continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results